325- Ng WF, Bowman SJ. Primary Sjogren’s syndrome: too dry and too tired. Rheumatology
(Oxford). 2010;49:844–53. - Soliotis FC, Mavragani CP, Moutsopoulos HM. Central nervous system involvement in
Sjogren’s syndrome. Ann Rheum Dis. 2004;63:616–20. - Segal B, Bowman SJ, Fox PC, et al. Primary Sjögren’s syndrome: health experiences and
predictors of health quality among patients in the United States. Health Qual Life Outcomes.
2009;7:46. - El Miedany YM, Ahmed I, Mourad HG, et al. Quantitative ultrasonography and magnetic
resonance imaging of the parotid gland: can they replace the histopathologic studies in patients
with Sjogren’s syndrome? Joint Bone Spine. 2004;71:29–38. - Vitali C, Bombardieri S, Jonsson R, European Study Group on Classifi cation Criteria for
Sjögren’s Syndrome, et al. Classifi cation criteria for Sjögren’s syndrome: a revised version of
the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis.
2002;61:554–8. - Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjögren syndrome: a
systematic review. JAMA. 2010;304:452–60. - Seror R, Ravaud P, Bowman SJ, EULAR Sjögren’s Task Force, et al. EULAR Sjogren’s syn-
drome disease activity index: development of a consensus systemic disease activity index for
primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69:1103–9. - Seror R, Ravaud P, Mariette X, et al. EULAR Sjogren’s syndrome patient reported index
(ESSPRI). Development of consensus patient complex for primary Sjogren’s syndrome. Ann
Rheum Dis. 2011;70:968–72. - Brito-Zerón P, Kostov B, Solans R, SS Study Group, Autoimmune Diseases Study Group
(GEAS), Spanish Society of Internal Medicine (SEMI), et al. Systemic activity and mortality
in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity
Index (ESSDAI) in 1045 patients. Ann Rheum Dis. 2016;75(2):348–55. - Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Primary Sjögren syndrome: hematologic
patterns of disease expression. Medicine (Baltimore). 2002;81:281–92. - El Miedany Y. PROMs in infl ammatory arthritis: moving from static to dynamic. Clin
Rheumatol. 2013;32:735–42. - Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjogren’s
syndrome using a new questionnaire tool. Rheumatology (Oxford). 2004;43:758–64. - Meiners PM, Arends S, Brouwer E. Responsiveness of disease activity indices ESSPRI and
ESSDAI in patients with primary Sjogren’s syndrome treated with rituximab. Ann Rheum Dis.
2012;71:1297–302. - Seror R, Mariette X, Bowman S, et al. Accurate detection of changes in disease activity in
primary Sjogren’s syndrome the European League Against Rheumatism Sjogren’s syndrome
Disease Activity Index. Arthritis Care Res. 2010;62:551–8. - Carr AJ, Thompson PW, Kirwan JR. Quality of life measures. Br J Rheumatol.
1996;35:275–81. - WHOQOL Group. Development of the QHOQOL: rationale and current status. Int J Ment
Health. 1994;23:24–56. - WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality
of life assessment. Psychol Med. 1998;28:551–8. - Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): conceptual
framework and item selection. Med Care. 1992;30:473–83. - EuroQoL Group. Euro-QoL—a new facility for the measurement of health related quality of
life. Health Policy. 1990;16:199–208. - Rajagopalan K, Abetz L, Merzanis P. Comparing the discriminate validity of two generic and
one disease specifi c health related quality of life measures in a sample of patients with dry eye.
Value Health. 2005;8:168–74. - Valtysdottir ST, Gudbjornsson B, Lindqvist U. Anxiety and depression in patients with pri-
mary Sjogren’s syndrome. J Rheumatol. 2000;27:165–9.
12 PROMs for Sjögren’s Syndrome